These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 17932562)

  • 1. LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.
    Grosso JF; Kelleher CC; Harris TJ; Maris CH; Hipkiss EL; De Marzo A; Anders R; Netto G; Getnet D; Bruno TC; Goldberg MV; Pardoll DM; Drake CG
    J Clin Invest; 2007 Nov; 117(11):3383-92. PubMed ID: 17932562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo.
    Workman CJ; Cauley LS; Kim IJ; Blackman MA; Woodland DL; Vignali DA
    J Immunol; 2004 May; 172(9):5450-5. PubMed ID: 15100286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells.
    Grosso JF; Goldberg MV; Getnet D; Bruno TC; Yen HR; Pyle KJ; Hipkiss E; Vignali DA; Pardoll DM; Drake CG
    J Immunol; 2009 Jun; 182(11):6659-69. PubMed ID: 19454660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.
    Cook KD; Whitmire JK
    J Immunol; 2016 Jul; 197(1):119-27. PubMed ID: 27206765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.
    Maçon-Lemaître L; Triebel F
    Immunology; 2005 Jun; 115(2):170-8. PubMed ID: 15885122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
    Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
    Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells.
    Nelson CE; Mills LJ; McCurtain JL; Thompson EA; Seelig DM; Bhela S; Quarnstrom CF; Fife BT; Vezys V
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2640-2645. PubMed ID: 30679280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
    Matsuzaki J; Gnjatic S; Mhawech-Fauceglia P; Beck A; Miller A; Tsuji T; Eppolito C; Qian F; Lele S; Shrikant P; Old LJ; Odunsi K
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7875-80. PubMed ID: 20385810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and function of immunosuppressive human and murine CD8+ T cells by transforming growth factor-β and retinoic acid.
    Fleissner D; Frede A; Knott M; Knuschke T; Geffers R; Hansen W; Dobos G; Langhorst J; Buer J; Westendorf AM
    Immunology; 2011 Sep; 134(1):82-92. PubMed ID: 21711349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8(+) T cell in HCC patients.
    Li FJ; Zhang Y; Jin GX; Yao L; Wu DQ
    Immunol Lett; 2013 Feb; 150(1-2):116-22. PubMed ID: 23261718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
    Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
    J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte activation gene 3 negatively regulates the function of intrahepatic hepatitis C virus-specific CD8+ T cells.
    Chen N; Liu Y; Guo Y; Chen Y; Liu X; Liu M
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1788-95. PubMed ID: 26095288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
    Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
    J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7h (ICOS-L) maintains tolerance at the fetomaternal interface.
    Riella LV; Dada S; Chabtini L; Smith B; Huang L; Dakle P; Mfarrej B; D'Addio F; Adams LT; Kochupurakkal N; Vergani A; Fiorina P; Mellor AL; Sharpe AH; Yagita H; Guleria I
    Am J Pathol; 2013 Jun; 182(6):2204-13. PubMed ID: 23578385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of LAG-3 in PD-L1-Deficient Mice Enhances Clearance of Blood Stage Malaria Independent of Humoral Responses.
    Furtado R; Chorro L; Zimmerman N; Guillen E; Spaulding E; Chin SS; Daily JP; Lauvau G
    Front Immunol; 2020; 11():576743. PubMed ID: 33519801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated murine endothelial cells have reduced immunogenicity for CD8+ T cells: a mechanism of immunoregulation?
    Marelli-Berg FM; Scott D; Bartok I; Peek E; Dyson J; Lechler RI
    J Immunol; 2000 Oct; 165(8):4182-9. PubMed ID: 11035050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors.
    Thompson ED; Enriquez HL; Fu YX; Engelhard VH
    J Exp Med; 2010 Aug; 207(8):1791-804. PubMed ID: 20660615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
    Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.